Overall survival (OS) with afatinib (A) vs chemotherapy (CT) in patients (pts) with NSCLC harboring EGFR mutations (mut): Subgroup analyses by race in LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)
Other conference paper


Full Text

Times Cited
Web of Science0WOS source URL (as at 23/10/2020) Click here for the latest count

Other information
All Author(s) ListWu YL, Sequist LV, Schuler M, Yamamoto N, Zhou C, Hu CP, O'Byrne K, Hirsh V, Mok T, Zazulina V, Yang JCH
Name of ConferenceAsia Congress of the European-Society-for-Medical-Oncology (ESMO)
Start Date of Conference18/12/2015
End Date of Conference21/12/2015
Place of ConferenceSingapore
Country/Region of ConferenceSingapore
Journal nameAnnals of Oncology
Detailed descriptionorganized by European Society for Medical Oncology,
Year2015
Month12
Day1
Volume Number26
PublisherOXFORD UNIV PRESS
Pages136 - 136
ISSN0923-7534
eISSN1569-8041
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology

Last updated on 2020-24-10 at 02:46